about
The rationale for BAFF inhibition in systemic lupus erythematosusResolve, revise, and relax: the 3 Rs of B cell repertoire adjustmentMechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary ImmunodeficienciesMechanisms of autoantibody production in systemic lupus erythematosusmiRNAs in the Pathogenesis of Systemic Lupus ErythematosusThe pathogenesis of systemic lupus erythematosus—an updateThe pathology of T cells in systemic lupus erythematosusIL-10 and lymphotoxin-α expression profiles within marginal zone-like B-cell populations are associated with control of HIV-1 disease progression.The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and diseaseEfficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis.DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titersBAFF/APRIL inhibition decreases selection of naive but not antigen-induced autoreactive B cells in murine systemic lupus erythematosusInfluence of dendritic cells on B-cell responses during HIV infection.Reversing Tolerance in Isotype Switch-Competent Anti-Insulin B Lymphocytes.Janus-like effects of type I interferon in autoimmune diseases.Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance.Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation.B-cell selection and the development of autoantibodies.B-cell activating factor targeted therapy and lupus.Taming lupus-a new understanding of pathogenesis is leading to clinical advances.Protein kinase Cβ is required for lupus development in Sle miceThe effect of BAFF inhibition on autoreactive B cell selection in murine SLE.B cell activating factor inhibition impairs bacterial immunity by reducing T cell-independent IgM secretion.BAFF promotes regulatory T-cell apoptosis and blocks cytokine production by activating B cells in primary biliary cirrhosis.Role of BAFF in pulmonary autoantibody responses induced by chronic cigarette smoke exposure in mice.Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.Belimumab for the management of systemic lupus erythematosus.Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown.B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab.The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.Immunopathology of lupus nephritis.B-cell hyperactivity in primary Sjögren's syndrome.Multiple potential roles for B cells in atherosclerosis.Regulatory B Cells and Mechanisms.B cells biology in systemic lupus erythematosus-from bench to bedside.Lupus nephritis and B-cell targeting therapy.New insights into the immunopathogenesis of systemic lupus erythematosus.Hydroxychloroquine in systemic lupus erythematosus (SLE).
P2860
Q26827373-D3718103-9C96-46DE-9712-F11A00E2C504Q26852927-448062F1-56C7-4DAE-8EE9-E868E4497F28Q28066193-99A6435A-147E-4AAE-94CF-10BD912F4A37Q28082507-504EF17F-0915-44CF-8721-CB13B6934307Q28083028-CDEB031D-B50F-47BA-BA61-48B0DA15B755Q29394347-CAE15EA6-E378-41E4-8A29-C80F41BBCFB0Q33598213-B42EE5F9-4793-469C-AAC2-1911D15B9CB8Q33864415-B5A5DBAE-4A6C-443A-AD66-9B32C6844278Q34373452-7F7C37B3-5DC5-466F-90DE-478D2B4AE7E3Q34667834-DB1BF949-C26E-4E42-B205-B81EA3F1D6A6Q35452032-F727C36F-0AFE-4AC7-A52C-828F32BE335FQ35568194-B9DAE9CC-393C-4A12-AECC-3398D58C1FA5Q35640984-98DFC1B7-55BE-4F2F-A232-8D2CE3A50446Q35686772-3FD2319D-8274-4230-A08B-64E5A195DBA4Q35810658-F4854586-13FC-416D-BA69-CF2C658E8B56Q35864642-577F765E-18A4-498B-8659-EB52CF0D4B5CQ36059960-B65AA099-7065-466B-BA5D-333C02E55147Q36245856-B15DC219-9F0A-4282-A3F6-808BA866DB23Q36273261-FF8C78AF-C14F-4F90-AE5F-6CE9CEB19CC8Q36504635-0AA0E424-09D4-4C43-9AE8-E53A6CA29E7FQ36504641-A7D79ED4-7EC7-40CC-8085-CD59A5B4CFF9Q36712941-CB2DF7A2-1121-4FF2-8A33-241B634FD03CQ37146459-840A1487-4C2B-4D19-97C9-17CCA6F20D6DQ37217047-2A30FD2C-61BC-4521-97DF-D160DF7F3920Q37336043-820C0CE6-1F1E-4AF4-95F0-8023633D23BEQ37371434-77E367A4-8BCF-4118-9E6F-F8BB71B541A3Q37556221-9D0E3B0E-98EF-4598-8045-1C85D1A31535Q37662690-8BA9158C-E700-48B3-85C0-9FA23D4DB96BQ38014539-4828E64D-B8C0-4BF6-BB84-8E4C13346314Q38023852-BBEAF940-B368-49A0-9817-B52793B96BF1Q38051302-B3F3E90B-510E-4D5B-A745-E9AC2ECC6858Q38115525-9F8BA928-B6B0-40FC-AE6B-543F70786309Q38176819-EF3020F7-BD05-4CDA-9AB0-C71299B3855FQ38190590-CE8F3C9A-93CF-4D7D-B206-EC2ABD9ED8B1Q38210609-D3CD9837-67FA-467C-B6A2-7DA814D644A6Q38385328-C2F13308-B936-4BE4-85EE-7AEBCEF2FE83Q38631964-E282E07D-7A08-49AE-BC6E-EB5C8EC99980Q38643755-F9220DAC-80A4-4861-8DA6-1FF7E1810634Q39016144-4C8FC287-9F70-4D28-8F1C-435E3CFC2160Q39031764-DA35FFA5-157D-4DC7-8969-6CC8F5989B8B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BAFF and selection of autoreactive B cells
@en
BAFF and selection of autoreactive B cells.
@nl
type
label
BAFF and selection of autoreactive B cells
@en
BAFF and selection of autoreactive B cells.
@nl
prefLabel
BAFF and selection of autoreactive B cells
@en
BAFF and selection of autoreactive B cells.
@nl
P2860
P356
P1433
P1476
BAFF and selection of autoreactive B cells
@en
P2093
P2860
P304
P356
10.1016/J.IT.2011.06.004
P577
2011-07-13T00:00:00Z